$VICR

VINCIARELLI PATRIZIO sold $378K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 1,200 shares of VICOR CORP (VICR) at $315.06 ($0.38M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 2, 2026, 7:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 7:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The key tradable element is the disclosed insider sale size and whether it is 10b5-1 pre-arranged (it is), which typically lowers the probability of a strong negative fundamental read-through.

02

Market read

Routine insider selling disclosure for VICR; sentiment impact is likely limited due to 10b5-1 plan context.

03

What to watch

Traders may ignore that holdings remain very large post-sale; also, the filing date may lag execution, so immediate price reaction may not reflect the actual sale timing.

Relevance 6/10Novelty 6/10Timing: Filed today; sale executed 2026-06-01

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

SEC Form 4 shows VICR CEO/Chairman sold 1,200 shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction likely fades unless accompanied by other negative news.

Evidence & confidence

The filing is a routine insider transaction with explicit 10b5-1 plan disclosure and no accompanying operational/business update.

Market effects

Minimal—single-company insider transaction without sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, the market may overreact; the disclosure could be largely mechanical rather than bearish.

Key entities

  • VICOR CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO; executed an open-market sale under a pre-arranged 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: